Immunoproteomics and reverse vaccinology identify a protective T-cell epitope from Fonsecaea pedrosoi for experimental chromoblastomycosis.

de Godoy Menezes I, Pereira BV, Albuquerque RC, de Almeida SR

Open source

DOI
10.1016/j.vaccine.2026.128902
Published
2026 Aug 30
Container
Vaccine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.vaccine.2026.128902,
  title = {Immunoproteomics and reverse vaccinology identify a protective T-cell epitope from Fonsecaea pedrosoi for experimental chromoblastomycosis.},
  author = {de Godoy Menezes I and Pereira BV and Albuquerque RC and de Almeida SR},
  year = {2026},
  journal = {Vaccine},
  doi = {10.1016/j.vaccine.2026.128902},
  url = {https://doi.org/10.1016/j.vaccine.2026.128902}
}

RIS

TY  - JOUR
TI  - Immunoproteomics and reverse vaccinology identify a protective T-cell epitope from Fonsecaea pedrosoi for experimental chromoblastomycosis.
AU  - de Godoy Menezes I
AU  - Pereira BV
AU  - Albuquerque RC
AU  - de Almeida SR
PY  - 2026
JO  - Vaccine
DO  - 10.1016/j.vaccine.2026.128902
UR  - https://doi.org/10.1016/j.vaccine.2026.128902
ER  - 

APA

I, D. G. M., BV, P., RC, A., & SR, D. A. (2026). Immunoproteomics and reverse vaccinology identify a protective T-cell epitope from Fonsecaea pedrosoi for experimental chromoblastomycosis.. Vaccine. https://doi.org/10.1016/j.vaccine.2026.128902

Source records